FDA Inspection 1158313 — Pfizer, Inc.
The FDA completed an inspection of Pfizer, Inc. on November 19, 2021 in Groton, CT. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 19, 2021
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Groton, CT (United States)